Opus Genetics, Inc.
IRD
$1.15
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.88M | 4.37M | 4.30M | 3.87M | 1.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.88M | 4.37M | 4.30M | 3.87M | 1.11M |
| Cost of Revenue | 5.96M | 7.89M | 7.78M | 8.75M | 6.08M |
| Gross Profit | -3.08M | -3.52M | -3.48M | -4.88M | -4.97M |
| SG&A Expenses | 5.83M | 6.41M | 7.27M | 2.90M | 3.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.79M | 14.30M | 14.33M | 11.88M | 9.44M |
| Operating Income | -8.91M | -9.93M | -10.03M | -8.01M | -8.33M |
| Income Before Tax | -7.42M | -8.19M | -35.14M | -7.53M | -7.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.42M | -8.19M | -35.14M | -7.53M | -7.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.42M | -8.19M | -35.14M | -7.53M | -7.77M |
| EBIT | -8.91M | -9.93M | -10.03M | -8.01M | -8.33M |
| EBITDA | -8.89M | -9.92M | -10.03M | -8.01M | -8.33M |
| EPS Basic | -0.12 | -0.24 | -1.16 | -0.29 | -0.30 |
| Normalized Basic EPS | -0.07 | -0.15 | -0.15 | -0.18 | -0.19 |
| EPS Diluted | -0.12 | -0.24 | -1.16 | -0.29 | -0.30 |
| Normalized Diluted EPS | -0.07 | -0.15 | -0.15 | -0.18 | -0.19 |
| Average Basic Shares Outstanding | 63.38M | 33.88M | 30.36M | 26.15M | 25.83M |
| Average Diluted Shares Outstanding | 63.38M | 33.88M | 30.36M | 26.15M | 25.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |